Inside Innovation

Kestra Medical Technologies, a Kirkland-based biotechnology company specializing in wearable defibrillators, has raised $196 million in its latest funding round. In a recent release, CEO

Seattle and the Greater Puget Sound continue to rank among the top biopharma clusters in the U.S., securing the #10 spot this year.  GEN’s four

The Allen Institute for AI (AI2) has leased a full floor in the Northlake Commons building, encompassing 50,000 square feet.  Founded by the late Microsoft

Bonum Therapeutics, a Seattle-based biomanufacturer, is moving into new offices in South Lake Union and plans to double its workforce in pursuit of producing its

The University of Washington School of Medicine has developed the capability for genomes to store information in real-time about a variety of biological events inside

The Steve Gleason Institute has become a leading treatment center for neurodegenerative diseases in the Pacific Northwest. Named after former Washington State University and New

The Department of Defense (DOD) has partnered with Just – Evotec Biologics, a Seattle-based subsidiary of Evotec, to enhance large-scale manufacturing capabilities under the DOD’s

Principal investors at Fred Hutch Cancer Center and UW Medicine received $5.25 million in grants from the Kuni Foundation, a Vancouver, Washington-based organization dedicated to

RareCyte, a Seattle-based biotech company, recently announced that it has raised $20 million from new and current investors. This funding boost is set to significantly

Ezra, a health technology startup focused on cancer screening, opened two new locations in the Seattle area this week. Emphasizing early detection, Ezra specializes in

Seattle has been ranked as the third-best city for new college graduates according to a recent study by Zumper. The study analyzed the country’s 100